---
layout: leftnav-page-content
title: International Advisory Panel
permalink: /who-we-are/international-advisory-panel/
breadcrumb: International Advisory Panel
collection_name: who-we-are
---

The International Advisory Panel (IAP) plays a critical advisory role to ACE to ensure that our processes and methods are in line with international standards, and to offer expert perspective on the global trends and developments in HTA to inform ACE’s development. It comprises of senior overseas experts who have served in leadership roles of reputable HTA bodies. IAP members are appointed for a 2-year term starting from 1 Mar 2017 to 28 Feb 2019.

The IAP's terms of reference:

* Critique, recommend improvements and endorse ACE’s methods and processes;
* Provide insights on emerging trends and developments in HTA;
* Share approaches to HTA implementation to guide Singapore’s HTA implementation efforts; and
* Connect ACE to international networks in the area of HTA.

### **IAP Members**

**Prof Jonathan Craig**<br>
Professor of Clinical Epidemiology, School of Public Health University of Sydney, Australia <br>
Coordinating editor of the Cochrane Kidney and Transplant Group <br>
Member of Pharmaceutical Benefits Advisory Committee (PBAC) & Medical Services Advisory Committee (MSAC)

**Prof Ron Goeree**<br>
Professor Emeritus, McMaster University, Canada<br> 
Founding Director, Program for Assessment of Technology in Health <br>
Involved in numerous research projects with Canadian Agency for Drugs and Technologies in Health (CADTH)